ConductScience.org, home

Gene · 10

Papers3,552

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

461 to 480 of 3,552

Download this page as JSON
TitleJournalYearPMIDFound bySource
The Promise of Nanotechnology in Personalized Medicine.J Pers Med202235629095PubTator, text miningPubMed
Technical Performance of a 430-Gene Preventative Genomics Assay to Identify Multiple Variant Types Associated with Adult-Onset Monogenic Conditions, Susceptibility Loci, and Pharmacogenetic Insights.J Pers Med202235629091PubTator, text miningPubMed
Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis.Biomedicines202235625789PubTator, text miningPubMed
NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity.Pharmacogenomics202235615896PubTator, text miningPubMed
The role of arylamine N-acetyltransferases in chronic degenerative diseases: Their possible function in the immune system.Biochim Biophys Acta Mol Cell Res202235588943PubTator, text miningPubMed
Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs.Mem Inst Oswaldo Cruz202235588539PubTator, text miningPubMed
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.J Clin Pharmacol202235588142PubTator, text miningPubMed
Antimicrobial resistance genes in microbiota associated with sediments and water from the Akaki river in Ethiopia.Environ Sci Pollut Res Int202235583762PubTator, text miningPubMed
Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation.Healthc Inform Res202235576986PubTator, text miningPubMed
An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.Front Pharmacol202235548363PubTator, text miningPubMed
CYP2S1 rs338599 polymorphism confers reduced risk to anti-tuberculosis drug-induced liver injury and may be a novel marker for its risk prediction.J Clin Lab Anal202235535391PubTator, text miningPubMed
Bacterial diversity and the antimicrobial resistome in the southwestern highlands of Saudi Arabia.Saudi J Biol Sci202235531257PubTator, text miningPubMed
Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.Acta Pharm Sin B202235530147PubTator, text miningPubMed
Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.Evid Based Complement Alternat Med202235509623PubTator, text miningPubMed
Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital.Health Sci Rep202235509409PubTator, text miningPubMed
Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma.Comput Struct Biotechnol J202235495118PubTator, text miningPubMed
Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model.J Tradit Complement Med202235493312PubTator, text miningPubMed
Polymorphism association of NIL1, NIL2, CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population.Pol Przegl Chir202235485310PubTator, text miningPubMed
Consumption of Thermally Processed Meat Containing Carcinogenic Compounds (Polycyclic Aromatic Hydrocarbons and Heterocyclic Aromatic Amines) versus a Risk of Some Cancers in Humans and the Possibility of Reducing Their Formation by Natural Food Additives-A Literature Review.
Int J Environ Res Public Health202235457645PubTator, text miningPubMed
Polymorphisms in Genes Involved in Inflammation and Periodontitis: A Narrative Review.Biomolecules202235454140PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10/papers?page=24